SCHEDULE 13G
Statement of Beneficial Ownership
Attovia Therapeutics, Inc. Filed Acc 0000886982-26-000642
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| GOLDMAN SACHS GROUP INC | 3,041,575 | 6.7% |
| GOLDMAN SACHS & CO. LLC | 3,041,575 | 6.7% |
| WEST STREET LIFE SCIENCES I, L.P. | 808,520 | 1.8% |
| WSLS OFFSHORE INVESTMENTS, SLP | 770,801 | 1.7% |
| WSLS EMP ONSHORE INVESTMENTS, L.P. | 574,750 | 1.3% |
| BROAD STREET PRINCIPAL INVESTMENTS, L.L.C. | 564,755 | 1.2% |
| WSLS EMP OFFSHORE INVESTMENTS, L.P. | 216,806 | 0.5% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…